Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Transgene

Founders Pierre Chambon

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$2M
Portfolio companies 1
Rounds per year 0.02
Lead investments 1
Key employees Soon

Areas of investment

  • Therapeutics
  • Biotechnology
  • Health Care

Look at other 50 related and similar funds Collapse list
Fund NameLocation
58.com Beijing, Beijing, China
Allos Therapeutics Colorado, United States, Westminster
Andurance Ventures England, London, United Kingdom
Circle Ventures New York, New York, United States
Dada Firenze, Italy, Toscana
Denham Capital Boston, Massachusetts, United States
Global Atlantic Atlanta, Georgia, United States
Hoop Partners -
Indiegogo California, San Francisco, United States
MEGA Holding Italy, Lombardy, Milan
Obvious Ventures California, San Francisco, United States
PAR Florida, Lutz, United States
Platform Partners Houston, Texas, United States
Prologis Ventures California, San Francisco, United States
R-H Capital Partners California, San Diego, United States
Regiment Capital Boston, Massachusetts, United States
Ruizheng Investment -
Sarwa Capital Al Qahirah, Cairo, Egypt
The Kuok Group Johor, Johor Bahru, Malaysia
Venture Tech Associates -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

ElsaLys Biotech

Biotechnology
Health Care
Therapeutics
$2M17 May 2013 Auvergne-Rhône-Alpes

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Transgene?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: